1. Home
  2. CCRN vs KMDA Comparison

CCRN vs KMDA Comparison

Compare CCRN & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCRN
  • KMDA
  • Stock Information
  • Founded
  • CCRN 1986
  • KMDA 1990
  • Country
  • CCRN United States
  • KMDA Israel
  • Employees
  • CCRN N/A
  • KMDA N/A
  • Industry
  • CCRN Professional Services
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCRN Consumer Discretionary
  • KMDA Health Care
  • Exchange
  • CCRN Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • CCRN 447.2M
  • KMDA 410.6M
  • IPO Year
  • CCRN N/A
  • KMDA N/A
  • Fundamental
  • Price
  • CCRN $13.12
  • KMDA $6.90
  • Analyst Decision
  • CCRN Hold
  • KMDA Strong Buy
  • Analyst Count
  • CCRN 5
  • KMDA 2
  • Target Price
  • CCRN $17.93
  • KMDA $13.00
  • AVG Volume (30 Days)
  • CCRN 368.8K
  • KMDA 50.0K
  • Earning Date
  • CCRN 11-05-2025
  • KMDA 11-12-2025
  • Dividend Yield
  • CCRN N/A
  • KMDA 2.90%
  • EPS Growth
  • CCRN N/A
  • KMDA 27.97
  • EPS
  • CCRN N/A
  • KMDA 0.32
  • Revenue
  • CCRN $1,192,539,000.00
  • KMDA $169,517,000.00
  • Revenue This Year
  • CCRN N/A
  • KMDA $14.49
  • Revenue Next Year
  • CCRN N/A
  • KMDA $10.12
  • P/E Ratio
  • CCRN N/A
  • KMDA $20.92
  • Revenue Growth
  • CCRN N/A
  • KMDA 9.67
  • 52 Week Low
  • CCRN $9.58
  • KMDA $5.17
  • 52 Week High
  • CCRN $18.33
  • KMDA $9.16
  • Technical
  • Relative Strength Index (RSI)
  • CCRN 47.85
  • KMDA 42.54
  • Support Level
  • CCRN $11.09
  • KMDA $6.80
  • Resistance Level
  • CCRN $14.30
  • KMDA $7.15
  • Average True Range (ATR)
  • CCRN 0.67
  • KMDA 0.20
  • MACD
  • CCRN -0.09
  • KMDA -0.00
  • Stochastic Oscillator
  • CCRN 63.24
  • KMDA 15.87

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: